BRANDI BLANTON: Open Payments
NPI 1871999292 · BUCYRUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 72 payments from 18 companies in 2025. Trend: 2023 $546 · 2024 $1,038 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $259 |
| AstraZeneca Pharmaceuticals LP | 11 | $182 |
| Lilly USA, LLC | 5 | $84 |
| Amgen Inc. | 4 | $78 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Novo Nordisk Inc | 4 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Exact Sciences Corporation | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $40 |
Products named: AIRSUPRA, VRAYLAR, Auvelity, TRELEGY ELLIPTA, Wegovy, UBRELVY, EVENITY, LINZESS.
Industry payments across OH — which companies pay providers there.
